Indoco Remedies' AnaCipher Gets Brazil ANVISA Approval

Indoco Remedies Ltd. announced that its Clinical Research Organisation, AnaCipher, has received approval from Brazil's National Health Surveillance Agency (ANVISA) for its clinical and bioanalytical facilities. This approval, following an inspection from March 30 to April 7, 2026, authorizes AnaCipher to conduct Bioavailability & Bioequivalence studies for submission to Brazil, along with associated bioanalytical support. Ms. Aditi Panandikar, MD, Indoco Remedies, stated that this reflects the CRO's robust quality systems and adherence to international standards, enhancing its ability to support pharmaceutical companies in Brazil and Latin America. AnaCipher is already accredited by several global regulatory bodies, including USFDA and EMA.